These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 27503183)

  • 21. Rationale, design, and baseline characteristics of a study to evaluate the effect of febuxostat in preventing cerebral, cardiovascular, and renal events in patients with hyperuricemia.
    Kojima S; Matsui K; Ogawa H; Jinnouchi H; Hiramitsu S; Hayashi T; Yokota N; Kawai N; Tokutake E; Uchiyama K; Sugawara M; Kakuda H; Wakasa Y; Mori H; Hisatome I; Waki M; Ohya Y; Kimura K; Saito Y;
    J Cardiol; 2017 Jan; 69(1):169-175. PubMed ID: 27005768
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment of Hyperuricemia in Chronic Kidney Disease.
    Ramirez-Sandoval JC; Madero M
    Contrib Nephrol; 2018; 192():135-146. PubMed ID: 29393124
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of febuxostat on delaying chronic kidney disease progression: a randomized trial in China.
    Yang H; Li R; Li Q; Yan T; Li Y; Huang Q; Uchida S; Chang W
    Int Urol Nephrol; 2023 May; 55(5):1343-1352. PubMed ID: 36534221
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Urate-lowering therapy for CKD patients with asymptomatic hyperuricemia without proteinuria elucidated by attribute-based research in the FEATHER Study.
    Kataoka H; Mochizuki T; Ohara M; Tsuruta Y; Iwasa N; Yoshida R; Tsuchiya K; Nitta K; Kimura K; Hosoya T;
    Sci Rep; 2022 Mar; 12(1):3784. PubMed ID: 35260678
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Preservation of renal function during gout treatment with febuxostat: a quantitative study.
    Whelton A; MacDonald PA; Chefo S; Gunawardhana L
    Postgrad Med; 2013 Jan; 125(1):106-14. PubMed ID: 23391676
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A comparative study of efficacy and safety of febuxostat and allopurinol in pyrazinamide-induced hyperuricemic tubercular patients.
    Pichholiya M; Yadav AK; Luhadia SK; Tahashildar J; Aseri ML
    Indian J Pharmacol; 2016; 48(5):522-525. PubMed ID: 27721537
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Modeling and Simulation for Estimating the Influence of Renal Dysfunction on the Hypouricemic Effect of Febuxostat in Hyperuricemic Patients Due to Overproduction or Underexcretion of Uric Acid.
    Hirai T; Kimura T; Echizen H
    Biol Pharm Bull; 2016; 39(6):1013-21. PubMed ID: 27251504
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Suggested statistical reappraisal of data from comparative study of febuxostat and allopurinol in chronic kidney disease.
    Zelicoff A
    Clin Rheumatol; 2014 Dec; 33(12):1837. PubMed ID: 25277213
    [No Abstract]   [Full Text] [Related]  

  • 29. Effect of Febuxostat, a Xanthine Oxidase Inhibitor, on Cardiovascular Risk in Hyperuricemic Patients with Hypertension: A Prospective, Open-label, Pilot Study.
    Tani S; Nagao K; Hirayama A
    Clin Drug Investig; 2015 Dec; 35(12):823-31. PubMed ID: 26482071
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Febuxostat, a potential drug in the secondary prevention of cardiovascular disease with hyperuricemia.
    Xu C; Meng J
    Int J Cardiol; 2023 Jan; 370():367. PubMed ID: 36306952
    [No Abstract]   [Full Text] [Related]  

  • 31. Cost-effectiveness analysis of febuxostat in patients with gout in Spain.
    Perez-Ruiz F; Díaz-Torné C; Carcedo D
    J Med Econ; 2016 Jun; 19(6):604-10. PubMed ID: 26855041
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effective uric acid-lowering treatment for hypertensive patients with hyperuricemia.
    Ohta Y; Ishizuka A; Arima H; Hayashi S; Iwashima Y; Kishida M; Yoshihara F; Nakamura S; Kawano Y
    Hypertens Res; 2017 Mar; 40(3):259-263. PubMed ID: 27760998
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The efficacy of febuxostat 10 mg for the prevention of hyperuricemia associated with tumor lysis syndrome (TLS) in Japanese patients with non-Hodgkin's lymphoma
.
    Yasu T; Kobayashi S; Horii M; Kurokawa Y
    Int J Clin Pharmacol Ther; 2016 Dec; 54(12):1009-1012. PubMed ID: 27641217
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Febuxostat--treatment for hyperuricemia and gout?
    Moreland LW
    N Engl J Med; 2005 Dec; 353(23):2505-7. PubMed ID: 16339099
    [No Abstract]   [Full Text] [Related]  

  • 35. Women with gout: efficacy and safety of urate-lowering with febuxostat and allopurinol.
    Chohan S; Becker MA; MacDonald PA; Chefo S; Jackson RL
    Arthritis Care Res (Hoboken); 2012 Feb; 64(2):256-61. PubMed ID: 22052584
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Hyperuricemia, gout, pseudogout and concomitant diseases].
    Schmidt BM; Wagner AD
    Dtsch Med Wochenschr; 2011 Dec; 136(48):2489-91. PubMed ID: 22109583
    [No Abstract]   [Full Text] [Related]  

  • 37. Safety and efficacy of oral febuxostat for treatment of HLA-B*5801-negative gout: a randomized, open-label, multicentre, allopurinol-controlled study.
    Yu KH; Lai JH; Hsu PN; Chen DY; Chen CJ; Lin HY
    Scand J Rheumatol; 2016 Jul; 45(4):304-11. PubMed ID: 26771445
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of febuxostat versus allopurinol and placebo in reducing serum urate in subjects with hyperuricemia and gout: a 28-week, phase III, randomized, double-blind, parallel-group trial.
    Schumacher HR; Becker MA; Wortmann RL; Macdonald PA; Hunt B; Streit J; Lademacher C; Joseph-Ridge N
    Arthritis Rheum; 2008 Nov; 59(11):1540-8. PubMed ID: 18975369
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Febuxostat: a review of its use in the treatment of hyperuricaemia in patients with gout.
    Frampton JE
    Drugs; 2015 Mar; 75(4):427-38. PubMed ID: 25724536
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In Reply to 'Febuxostat for Asymptomatic Hyperuricemia in CKD' and 'Febuxostat Renoprotection in CKD Patients With Asymptomatic Hyperuricemia'.
    Sircar D
    Am J Kidney Dis; 2016 Jun; 67(6):990-1. PubMed ID: 27211369
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.